170 related articles for article (PubMed ID: 9545098)
1. Identification of heterozygotic carriers of 21-hydroxylase deficiency: sensitivity of ACTH stimulation tests.
Witchel SF; Lee PA
Am J Med Genet; 1998 Apr; 76(4):337-42. PubMed ID: 9545098
[TBL] [Abstract][Full Text] [Related]
2. Hyperandrogenism in carriers of CYP21 mutations: the role of genotype.
Admoni O; Israel S; Lavi I; Gur M; Tenenbaum-Rakover Y
Clin Endocrinol (Oxf); 2006 Jun; 64(6):645-51. PubMed ID: 16712666
[TBL] [Abstract][Full Text] [Related]
3. Variable ACTH-stimulated 17-hydroxyprogesterone values in 21-hydroxylase deficiency carriers are not related to the different CYP21 gene mutations.
Bachega TA; Brenlha EM; Billerbeck AE; Marcondes JA; Madureira G; Arnhold IJ; Mendonca BB
J Clin Endocrinol Metab; 2002 Feb; 87(2):786-90. PubMed ID: 11836321
[TBL] [Abstract][Full Text] [Related]
4. The presence of the 21-hydroxylase deficiency carrier status in hirsute women: phenotype-genotype correlations.
Escobar-Morreale HF; San Millán JL; Smith RR; Sancho J; Witchel SF
Fertil Steril; 1999 Oct; 72(4):629-38. PubMed ID: 10521100
[TBL] [Abstract][Full Text] [Related]
5. Genotype and hormonal phenotype in nonclassical 21-hydroxylase deficiency.
Speiser PW; New MI
J Clin Endocrinol Metab; 1987 Jan; 64(1):86-91. PubMed ID: 3023431
[TBL] [Abstract][Full Text] [Related]
6. The frequency of CYP 21 gene mutations in Turkish women with hyperandrogenism.
Kelestimur F; Everest H; Dundar M; Tanriverdi F; White C; Witchel SF
Exp Clin Endocrinol Diabetes; 2009 May; 117(5):205-8. PubMed ID: 19085698
[TBL] [Abstract][Full Text] [Related]
7. Evidence for a heterozygote advantage in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Witchel SF; Lee PA; Suda-Hartman M; Trucco M; Hoffman EP
J Clin Endocrinol Metab; 1997 Jul; 82(7):2097-101. PubMed ID: 9215278
[TBL] [Abstract][Full Text] [Related]
8. Genotype-phenotype analysis in late onset 21-hydroxylase deficiency in comparison to the classical forms.
Rumsby G; Avey CJ; Conway GS; Honour JW
Clin Endocrinol (Oxf); 1998 Jun; 48(6):707-11. PubMed ID: 9713558
[TBL] [Abstract][Full Text] [Related]
9. Non-classical 21-hydroxylase deficiency in children: association of adrenocorticotropic hormone-stimulated 17-hydroxyprogesterone with the risk of compound heterozygosity with severe mutations.
Ezquieta B; Cueva E; Varela J; Oliver A; Fernández J; Jariego C
Acta Paediatr; 2002; 91(8):892-8. PubMed ID: 12222711
[TBL] [Abstract][Full Text] [Related]
10. Carriers for type II 3beta-hydroxysteroid dehydrogenase (HSD3B2) deficiency can only be identified by HSD3B2 genotype study and not by hormone test.
Pang S; Carbunaru G; Haider A; Copeland KC; Chang YT; Lutfallah C; Mason JI
Clin Endocrinol (Oxf); 2003 Mar; 58(3):323-31. PubMed ID: 12608938
[TBL] [Abstract][Full Text] [Related]
11. Influence of different genotypes on 17-hydroxyprogesterone levels in patients with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Bachega TA; Billerbeck AE; Marcondes JA; Madureira G; Arnhold IJ; Mendonca BB
Clin Endocrinol (Oxf); 2000 May; 52(5):601-7. PubMed ID: 10792340
[TBL] [Abstract][Full Text] [Related]
12. Correlation between genotype and hormonal levels in heterozygous mutation carriers and non-carriers of 21-hydroxylase deficiency.
Napolitano E; Manieri C; Restivo F; Composto E; Lanfranco F; Repici M; Pasini B; Einaudi S; Menegatti E
J Endocrinol Invest; 2011; 34(7):498-501. PubMed ID: 20671415
[TBL] [Abstract][Full Text] [Related]
13. Impaired mineralocorticoid hormone responses to adrenocorticotropin stimulation: additional characterization of heterozygosity for the 21-hydroxylase deficiency type of congenital adrenal hyperplasia.
Pardini DP; Kater CE; Vieira JG; Biglieri EG
J Clin Endocrinol Metab; 1983 Nov; 57(5):1061-6. PubMed ID: 6311859
[TBL] [Abstract][Full Text] [Related]
14. Hormonal evaluation and mutation screening for steroid 21-hydroxylase deficiency in patients with unilateral and bilateral adrenal incidentalomas.
Patócs A; Tóth M; Barta C; Sasvári-Székely M; Varga I; Szücs N; Jakab C; Gláz E; Rácz K
Eur J Endocrinol; 2002 Sep; 147(3):349-55. PubMed ID: 12213672
[TBL] [Abstract][Full Text] [Related]
15. Relationship of CYP21A2 genotype and serum 17-hydroxyprogesterone and cortisol levels in a large cohort of Italian children with premature pubarche.
Ghizzoni L; Cappa M; Vottero A; Ubertini G; Carta D; Di Iorgi N; Gasco V; Marchesi M; Raggi V; Ibba A; Napoli F; Massimi A; Maghnie M; Loche S; Porzio O
Eur J Endocrinol; 2011 Aug; 165(2):307-14. PubMed ID: 21646284
[TBL] [Abstract][Full Text] [Related]
16. Molecular analysis of the CYP21 gene and prenatal diagnosis in families with 21-hydroxylase deficiency in northeastern Iran.
Vakili R; Baradaran-Heravi A; Barid-Fatehi B; Gholamin M; Ghaemi N; Abbaszadegan MR
Horm Res; 2005; 63(3):119-24. PubMed ID: 15775714
[TBL] [Abstract][Full Text] [Related]
17. [Diagnosis of heterozygote carrier of mutant gene of 21-hydroxylase].
Dzenis IG; Iudina TN; Brykova EK; Bakharev VA; Fanchenko ND
Akush Ginekol (Mosk); 1995; (1):21-3. PubMed ID: 7762743
[TBL] [Abstract][Full Text] [Related]
18. LC-MS/MS based determination of basal- and ACTH-stimulated plasma concentrations of 11 steroid hormones: implications for detecting heterozygote CYP21A2 mutation carriers.
Kulle AE; Riepe FG; Hedderich J; Sippell WG; Schmitz J; Niermeyer L; Holterhus PM
Eur J Endocrinol; 2015 Oct; 173(4):517-24. PubMed ID: 26315375
[TBL] [Abstract][Full Text] [Related]
19. Superior discriminating value of ACTH-stimulated serum 21-deoxycortisol in identifying heterozygote carriers for 21-hydroxylase deficiency.
Costa-Barbosa FA; Tonetto-Fernandes VF; Carvalho VM; Nakamura OH; Moura V; Bachega TA; Vieira JG; Kater CE
Clin Endocrinol (Oxf); 2010 Dec; 73(6):700-6. PubMed ID: 20846292
[TBL] [Abstract][Full Text] [Related]
20. CYP21 mutations in Brazilian patients with 21-hydroxylase deficiency.
Witchel SF; Smith R; Crivellaro CE; Della Manna T; Dichtchekenian V; Setian N; Damiani D
Hum Genet; 2000 Apr; 106(4):414-9. PubMed ID: 10830908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
